Warning: The NCBI web site requires JavaScript to function. more...
Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis.
Kinderlerer AR, Steinberg R, Johns M, Harten SK, Lidington EA, Haskard DO, Maxwell PH, Mason JC.
Arthritis Res Ther. 2006;8(4):R130.
Related citations
Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
Mason JC, Ahmed Z, Mankoff R, Lidington EA, Ahmad S, Bhatia V, Kinderlerer A, Randi AM, Haskard DO.
Circ Res. 2002 Oct 18;91(8):696-703.
Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC.
J Thromb Haemost. 2007 Dec;5(12):2537-46. Epub 2007 Oct 8.
bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
Mason JC, Lidington EA, Ahmad SR, Haskard DO.
Am J Physiol Cell Physiol. 2002 Mar;282(3):C578-87.
3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
Wagner AH, Gebauer M, Güldenzoph B, Hecker M.
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1784-9.
Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
Mason JC, Lidington EA, Yarwood H, Lublin DM, Haskard DO.
Arthritis Rheum. 2001 Jan;44(1):138-50.
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F.
Cardiovasc Res. 2003 Sep 1;59(3):755-66.
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R.
Cardiovasc Res. 2010 May 1;86(2):311-20. Epub 2009 Nov 27.
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S.
J Clin Invest. 1998 Jun 15;101(12):2711-9.
Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW.
J Biol Chem. 2005 Jun 10;280(23):22212-21. Epub 2005 Apr 6.
Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.
Loboda A, Jazwa A, Jozkowicz A, Molema G, Dulak J.
Vascul Pharmacol. 2006 Apr;44(4):206-14. Epub 2006 Feb 14.
Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
Grubbs BC, Benson BA, Dalmasso AP.
Xenotransplantation. 2003 Sep;10(5):387-97.
Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.
Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, Dulak J.
Atherosclerosis. 2006 Jul;187(1):26-30. Epub 2006 Apr 18.
Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C, Alcudia JF, Martínez-González J, Guadall A, Raposo B, Sánchez-Gómez S, Badimon L.
Cardiovasc Res. 2009 Aug 1;83(3):595-603. Epub 2009 Apr 30.
Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H.
Br J Pharmacol. 2007 Feb;150(4):470-9. Epub 2007 Jan 15.
Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
Nakata S, Tsutsui M, Shimokawa H, Yamashita T, Tanimoto A, Tasaki H, Ozumi K, Sabanai K, Morishita T, Suda O, Hirano H, Sasaguri Y, Nakashima Y, Yanagihara N.
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):92-8. Epub 2006 Nov 2.
Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).
Arora M, Kumar A, Das SN, Srivastava LM.
Clin Exp Immunol. 1998 Jan;111(1):102-6.
Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells.
Kunii H, Shichishima T, Saitoh Y, Noji H, Maruyama Y.
Fukushima J Med Sci. 1998 Dec;44(2):69-81.
Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
Boerma M, Burton GR, Wang J, Fink LM, McGehee RE Jr, Hauer-Jensen M.
Blood Coagul Fibrinolysis. 2006 Apr;17(3):173-80.
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.
Ortego M, Hernández AG, Bustos C, Blanco-Colio LM, Hernández-Presa MA, Tuñón J, Egido J.
Eur J Pharmacol. 2002 Jul 19;448(2-3):113-21.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on